UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Pharmacologic Profile of the Dihydropyrimidine Calcium Channel Blockers SQ 32,547 and SQ 32,946

Journal of cardiovascular pharmacology, 1995-08, Vol.26 (2), p.289-294

1995

Volltextzugriff (PDF)

Cardioselective Antiischemic ATP-Sensitive Potassium Channel Openers. 2. Structure-Activity Studies on Benzopyranylcyanoguanidines; Modification of the Benzopyran Ring

Journal of medicinal chemistry, 1995-05, Vol.38 (11), p.1966-1973

1995

Volltextzugriff (PDF)

Cardioselective Antiischemic ATP-Sensitive Potassium Channel (KA TP) Openers. 6. Effect of Modifications at C6 of Benzopyranyl Cyanoguanidines

Journal of medicinal chemistry, 1999-09, Vol.42 (18), p.3711-3717

1999

Volltextzugriff (PDF)

Design and SAR of selective T-type calcium channel antagonists containing a biaryl sulfonamide core

Bioorganic & medicinal chemistry, 2008-01, Vol.18 (2), p.474-478

2008

Volltextzugriff (PDF)

Cardioselective Antiischemic ATP-Sensitive Potassium Channel (KATP) Openers. 5. Identification of 4-(N-Aryl)-Substituted Benzopyran Derivatives with High Selectivity

Journal of medicinal chemistry, 1997-01, Vol.40 (1), p.24-34

1997

Volltextzugriff (PDF)

Protective Effect of Serotonin (5-HT2) Receptor Antagonists in Ischemic Rat Hearts

Journal of cardiovascular pharmacology, 1993-10, Vol.22 (4), p.664-664

1993

Volltextzugriff (PDF)

Design and Synthesis of 4-Substituted Benzamides as Potent, Selective, and Orally Bioavailable I Ks Blockers

Journal of medicinal chemistry, 2001-11, Vol.44 (23), p.3764-3767

2001

Volltextzugriff (PDF)

Design and Synthesis of 4-Substituted Benzamides as Potent, Selective, and Orally Bioavailable IKs Blockers

Journal of medicinal chemistry, 2001-11, Vol.44 (23), p.3764-3767

2001

Volltextzugriff (PDF)

Pharmacological Characterization of the Isolated Canine Prostate

The Journal of urology, 1996-05, Vol.155 (5), p.1758-1761

1996

Volltextzugriff (PDF)

Tetrahydronaphthalene-derived amino alcohols and amino ketones as potent and selective inhibitors of the delayed rectifier potassium current IKs

Bioorganic & medicinal chemistry letters, 2004-01, Vol.14 (1), p.99-102

2004

Volltextzugriff (PDF)

Binding of ATP-Sensitive Potassium Channel (KATP) Openers to Cardiac Membranes: Correlation of Binding Affinities with Cardioprotective and Smooth Muscle Relaxing Potencies

Journal of medicinal chemistry, 1998-01, Vol.41 (3), p.271-275

1998

Volltextzugriff (PDF)

Cardioselective Antiischemic ATP-Sensitive Potassium Channel Openers. 4. Structure−Activity Studies on Benzopyranylcyanoguanidines: Replacement of the Benzopyran Portion

Journal of medicinal chemistry, 1996-01, Vol.39 (1), p.304-313

1996

Volltextzugriff (PDF)

Cardioselective Anti-Ischemic ATP-Sensitive Potassium Channel Openers. 3. Structure-Activity Studies on Benzopyranyl Cyanoguanidines; Modification of the Cyanoguanidine Portion

Journal of medicinal chemistry, 1995-08, Vol.38 (17), p.3236-3245

1995

Volltextzugriff (PDF)

Erratum: Pharmacologic Profile of the Dihydropyrimidine Calcium Channel Blockers SQ 32,547 and SQ 32,946

Journal of cardiovascular pharmacology, 1995-11, Vol.26 (5), p.845-845

1995

Volltextzugriff (PDF)

Specific Block of the Anti-Ischemic Actions of Cromakalim by Sodium 5-Hydroxydecanoate

Circulation research, 1991-10, Vol.69 (4), p.949-958

1991

Volltextzugriff (PDF)

Cardioselective anti-ischemic ATP-sensitive potassium channel openers

Journal of medicinal chemistry, 1993-11, Vol.36 (24), p.3971-3974

1993

Volltextzugriff (PDF)

Alterations in I to1, I Krand I k1Density in the BIO TO-2 Strain of Syrian Myopathic Hamsters

Journal of molecular and cellular cardiology, 1997, Vol.29 (12), p.3211-3221

1997

Volltextzugriff (PDF)

Pharmacological Characterization of the Isolated Canine Prostate

The Journal of urology, 1996-05, p.1758-1761

1996

Volltextzugriff (PDF)

Benzazepinone calcium channel blockers. 2. Structure activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinones

Journal of medicinal chemistry, 1992-02, Vol.35 (4), p.756-772

1992

Volltextzugriff (PDF)

A comparison between the effects of BMS-180448, a novel K+ channel opener, and cromakalim in rat and dog

European journal of pharmacology, 1995-12, Vol.294 (1), p.271-280

1995

Volltextzugriff (PDF)

Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site

Journal of medicinal chemistry, 1992-02, Vol.35 (4), p.780-793

1992

Volltextzugriff (PDF)

Aryl cyanoguanidine potassium channel openers

Bioorganic & medicinal chemistry letters, 1992, Vol.2 (1), p.83-86

1992

Volltextzugriff (PDF)

Benzopyranyl-cyanoguanidine potassium channel openers

Bioorganic & medicinal chemistry letters, 1992, Vol.2 (1), p.87-90

1992

Volltextzugriff (PDF)

The discovery of a novel calcium channel blocker related to the structure of potassium channel opener cromakalim

Bioorganic & medicinal chemistry letters, 1992-12, Vol.2 (12), p.1475-1478

1992

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacologic Profile of the Dihydropyrimidine Calcium Channel Blockers SQ 32,547 and SQ 32,946

Cardioselective Antiischemic ATP-Sensitive Potassium Channel Openers. 2. Structure-Activity Studies on Benzopyranylcyanoguanidines; Modification of the Benzopyran Ring

Cardioselective Antiischemic ATP-Sensitive Potassium Channel (KA TP) Openers. 6. Effect of Modifications at C6 of Benzopyranyl Cyanoguanidines

Design and SAR of selective T-type calcium channel antagonists containing a biaryl sulfonamide core

Cardioselective Antiischemic ATP-Sensitive Potassium Channel (KATP) Openers. 5. Identification of 4-(N-Aryl)-Substituted Benzopyran Derivatives with High Selectivity

Protective Effect of Serotonin (5-HT2) Receptor Antagonists in Ischemic Rat Hearts

Design and Synthesis of 4-Substituted Benzamides as Potent, Selective, and Orally Bioavailable I Ks Blockers

Design and Synthesis of 4-Substituted Benzamides as Potent, Selective, and Orally Bioavailable IKs Blockers

Pharmacological Characterization of the Isolated Canine Prostate

Tetrahydronaphthalene-derived amino alcohols and amino ketones as potent and selective inhibitors of the delayed rectifier potassium current IKs

Binding of ATP-Sensitive Potassium Channel (KATP) Openers to Cardiac Membranes: Correlation of Binding Affinities with Cardioprotective and Smooth Muscle Relaxing Potencies

Cardioselective Antiischemic ATP-Sensitive Potassium Channel Openers. 4. Structure−Activity Studies on Benzopyranylcyanoguanidines: Replacement of the Benzopyran Portion

Cardioselective Anti-Ischemic ATP-Sensitive Potassium Channel Openers. 3. Structure-Activity Studies on Benzopyranyl Cyanoguanidines; Modification of the Cyanoguanidine Portion

Erratum: Pharmacologic Profile of the Dihydropyrimidine Calcium Channel Blockers SQ 32,547 and SQ 32,946

Specific Block of the Anti-Ischemic Actions of Cromakalim by Sodium 5-Hydroxydecanoate

Cardioselective anti-ischemic ATP-sensitive potassium channel openers

Alterations in I to1, I Krand I k1Density in the BIO TO-2 Strain of Syrian Myopathic Hamsters

Pharmacological Characterization of the Isolated Canine Prostate

Benzazepinone calcium channel blockers. 2. Structure activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinones

A comparison between the effects of BMS-180448, a novel K+ channel opener, and cromakalim in rat and dog

Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site

Aryl cyanoguanidine potassium channel openers

Benzopyranyl-cyanoguanidine potassium channel openers

The discovery of a novel calcium channel blocker related to the structure of potassium channel opener cromakalim

Pathological correlations of [F‐18]‐AV‐1451 imaging in non‐alzheimer tauopathies

Suchergebnisse filtern